RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
120 hedge funds and large institutions have $1.05B invested in Revance Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 26 reducing their positions, and 16 closing their positions.
Holders
120
Holders Change
+5
Holders Change %
+4.35%
% of All Funds
2.75%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
21
Increased
52
Reduced
26
Closed
16
Calls
$3.14M
Puts
$1.35M
Net Calls
+$1.79M
Net Calls Change
+$8.8M
Top Buyers
1 |
1
Jennison Associates
New York
|
$45.7M |
2 |
2
Millennium Management
New York
|
$46M |
3 |
FI
3
Fosun International
Hong Kong,
China
|
$9.84M |
4 |
4
BlackRock
New York
|
$74.2M |
5 |
5
Wellington Management Group
Boston,
Massachusetts
|
$117M |